Back
Cabot Corp. 10K Form
Sell
46
CBT
Cabot Corp.
Last Price:
$76.94
Seasonality Move:
1.39%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-08-08 | 10Q | CBT/Cabot Corp. Quarterly |
| 2023-05-09 | 10Q | CBT/Cabot Corp. Quarterly |
| 2023-02-09 | 10Q | CBT/Cabot Corp. Quarterly |
| 2022-08-08 | 10Q | CBT/Cabot Corp. Quarterly |
| 2022-05-09 | 10Q | CBT/Cabot Corp. Quarterly |
| 2022-02-04 | 10Q | CBT/Cabot Corp. Quarterly |
Receive CBT News And Ratings
See the #1 stock for the next 7 days that we like better than CBT
CBT Financial Statistics
Sales & Book Value
| Annual Sales: | $3.7B |
|---|---|
| Cash Flow: | $57M |
| Price / Cash Flow: | 9.51 |
| Annual Sales: | $30.16 |
| Price / Book: | 2.52 |
Profitability
| EPS (TTM): | 5.69750 |
|---|---|
| Net Income (TTM): | $350M |
| Gross Margin: | $946M |
| Return on Equity: | 21.28% |
| Return on Assets: | 9.29% |
Cabot Corp. Earnings Forecast
Key Cabot Corp. Financial Ratios
-
The Gross Profit Margin over the past 46 years for CBT is 25.48%.
-
The Selling, General & Administrative Expenses for CBT have been equal to 7.00% of Gross Profit Margin.
-
The Research & Development expenses have been 1.54% of Revenue.
-
The Interest Expense is 21.24% of Operating Income.
-
The Net Earning history of CBT is 10.02% of Total Revenues.
-
Per Share Earnings over the last 46 years have been positive in 17 years.
Cabot Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Chemicals |
| Sector: | Materials |
| Current Symbol: | CBT |
| CUSIP: | 127055 |
| Website: | cabotcorp.com |
Debt
| Debt-to-Equity Ratio: | 0.71 |
|---|---|
| Current Ratio: | 1.67 |
| Quick Ratio: | 0.97 |
Price-to-Earnings
| Trailing P/E Ratio: | 12.62 |
|---|---|
| Forward P/E Ratio: | 10.92 |
CBT Technical Analysis vs Fundamental Analysis
Sell
46
Cabot Corp. (CBT)
is a Sell
Is Cabot Corp. a Buy or a Sell?
-
Cabot Corp. stock is rated a SellThe current Cabot Corp. [CBT] share price is $75.93. The Score for CBT is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.